Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis
Wei‐Ren Liu(Chung Yuan Christian University), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Jian Zhou(Shenzhen University Health Science Center), Chenyang Tao(Ministry of Education of the People's Republic of China), Han Wang(Ministry of Education of the People's Republic of China), Jia Fan(Nanjing Tech University), Zheng Tang(Ministry of Education of the People's Republic of China), Yuan Fang(Guangzhou University of Chinese Medicine), Shushu Song(Fudan University), Meng‐Xin Tian(Sun Yat-sen University), Xi‐Fei Jiang(Sun Yat-sen University), Zhen‐Bin Ding(Fudan University), Yufu Zhou(Central South University), Pei‐Yun Zhou(Fudan University)
Cited by 16
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644